Amelioration of Gastric Lesions by Avocado (Persea americana) fruit extract on Indomethacin as well as Ethanol induced Ulcerated Experimental rats

 

U.S. Mahadeva Rao and Bizuneh Adinew

Department of Chemistry, Mizan-Tepi University, P. O. No 121, Tepi, Ethiopia, East Africa

ABSTRACT:

In the present study, anti-ulcerogenic potential of Avocado fruit extract was evaluated using two different models of gastric lesions induced in experimental rats; 1) Indomethacin-induced gastric lesions and 2) Ethanol-induced gastric lesions. Pretreatment with oral administration of the extract of Avocado fruit extract (300mg/kg) prevented the formation of acute gastric lesion induced by both the experimental models: further, treatment with the ethanolic extract of Avocado fruit extract for a period of 15 days significantly reduced the ulcer index, ulcerated surface and significantly elevated the levels of glycoprotein contents in gastric juice.

 

 

KEYWORDS: Avocado. Anti-ulcerogenic effect.  Indomethacin- induced gastric lesion.  Ethanol- induced gastric lesion. Ulcer index

 

INTRODUCTION

The term ulcer (gastric lesion) was first coined by Quike in 1882 and it is now regarded as one of the most important gastrointestinal disorder1. Peptic gastric lesions are gastric lesions in the stomach or duodenum. These are the parts of gut where acids bath the surface. Gastric mucus is a highly hydrated viscoelatsic gel that protects the mucosa from the mechanical stress as well as from erosion by pepsin and HCl2. The polymer matrix of the gel is provided by the large secreted glycoprotein referred to as mucus glycoprotein or mucus which is produced by all cells in the surface of mucosa as well as by certain cells in the gastric gland3.

      

Peptic gastric lesions are caused when the natural balance between aggressive factors of acids and pepsin, and defensive mechanisms of mucus, bicarbonate and mucosal turnover is shifted in favor of the former4.Gastric lesion is caused by many factors like non-steroid anti-inflammatory drugs (NSAIDs), alcohols, smoking, Helicobacter pylori infection, stress etc. 5,. Five to ten percent of populations experience a peptic gastric lesion at some point in their lives. On rare occasions, a gastric lesion may be malignant.

 

A rational therapy for peptic gastric lesion still remains elusive and search for safer potential drugs as being carried out. Although H2 – receptors (ranitidine, famotidine), proton-pump inhibitors (omeprazole, lansoprazole), antibiotics (metronidazole, amoxicillin, clarithromycin, tetracycline etc.) and other drugs are currently used for the efficient management of the peptic gastric lesion diseases, they also have some limitation6,7.

 



The Avocado, unflatteringly known in the past as alligator pear, midshipman's butter, vegetable butter, or sometimes as butter pear, and called by Spanish-speaking people aguacate, cura, cupandra, or palta; in Portuguese, abacate; in French, avocatier; is the only important edible fruit of the laurel family, Lauraceae. It is botanically classified in three groups: A) Persea americana Mill. var. americana (P. gratissima Gaertn.), West Indian Avocado; B) P. americana Mill. var. drymifolia Blake (P. drymifolia Schlecht. & Cham.), the Mexican Avocado; C) P. nubigena var. guatemalensis L. Wms., the Guatemalan Avocado. It has traditionally been used for antibacterial, antifungal, hypotensive, and anti-inflammatory, anti-immune enhancer effect. Furthermore, Avocado juice, which is made from the ripe fruit, was very popular of its many health benefits.  The Avocado tree may be erect, usually to 30 ft (9 m) but sometimes to 60 ft (18 m) or more, with a trunk 12 to 24 in (30-60 cm) in diameter, (greater in very old trees) or it may be short and spreading with branches beginning close to the ground. Almost evergreen, being shed briefly in dry seasons at blooming time, the leaves are alternate, dark-green and glossy on the upper surface, whitish on the underside; variable in shape (lanceolate, elliptic, oval, ovate or obovate), 3 to 16 in (7.5-40 cm) long. Because limited reports on the fruits of Avocado were available in the literature, it was thought to be desirable to carry out systematic investigations on the fruits of this plant. Use of natural drugs in gastric gastric lesions is well documented8,9. Information provided by practitioners of African traditional medicine suggests that Avocado fruit possesses anti-gastric lesion remedy. The aim of this present study was to support the anti-gastric lesion effect by the amelioration of gastric lesions, attributed to Avocado fruit extract, by evaluating the anti-gastric lesion activity of an ethanolic as well as indomethacin extract of this fruit.

 

Chemical composition: 

According to Kadam, and Salunkhe, the Avocado has a high lipid content-from 5 to 25% depending on the cultivar. Among the saturated fatty acids, myristic level may be, 1%, palmitic, 7.2, 14.1 or 22.1%; stearic, 0.2, 0.6 or 1.7%. Of the unsaturated fatty acids, palmitoleic may range from 5.5 to 11.0%; oleic may be 51.9, 70.7 or 80.97%, linoleic, 9.3, 11.2 or 14.3%. Non saponifiable represents 1.6 to 2.4%. Iodine number is 94.4. Amino acids of the pulp (N = 16 p. 100) are recorded as: arginine, 3.4; cystine, 0.1: histidine, 1.8; isoleucine, 3.4; leucine, 5.5; lysine, 4.3;methionine, 2.1; phenylalanine, 3.5; threonine, 2.9; tryptophan, 0.1 ; tyrosine, 2.3; valine, 4.6; aspartic acid, 22.6; glutamic acid, 12.3; alanine, 6.0; glycine, 4.0; proline, 3.9; serine, 4.1 .

 

MATERIALS AND METHODS:

Plant material

Fresh fruits of P. americana were collected from its natural habitat in the Agricultural Research Center, Tepi, Ethiopia and were authenticated in the department of biology, Mizan-Tapi University, Tepi. The seed was removed and the edible part was chopped into small pieces, dried at 50-60°C and ground into powder. Known amount of dry powder was repeatedly extracted by the process of maceration in an aspirator using 95% ethanol as menstrum. The extract was concentrated under reduced pressure by rotary evaporator to obtain thick syrup mass, and stored at 4°C. The yield was approximately 10% of fresh fruit. Working concentrations of the extract were made in nonpyrogenic distilled water before use in the experiment. 

 

Experimental animals

Healthy, male albino rats of Wistar strain (150-170g) were selected for the present study. The rats were procured from Tepi Veterinary Center, Tepi, Ethiopia. Before beginning the experiments, the animals were allowed to acclimatize to animal house condition for a period of one week.

 

Pretreatment studies

Six groups of six rats each were pre-treated with single oral administration of Avocado fruit extract at a concentration of 300mg/kg body weight 1h before the gastric lesion inducing procedures. Gastric lesions was induced in 36h fasted rats by the oral administration of gastric lesion inducing drug, indomethacin (48mg/kg b.w)10 and necrotizing agent, 1ml of absolute ethanol11.The rats were killed 6h after indomethacin and 1h after the ethanol administration by an overdose of ether. The gastric gland were removed and opened along the greater curvature and the ulcer index was evaluated according to severity and gastric lesion scores.

 

Post treatment studies

Ethanol-induced Gastric lesion Model

Male Wistar rats weighing about 150-170g were divided into different groups each comprising of a minimum of 6 rats as detailed below.

Group I- Control rats (received 1ml of water)

Group II- Ethanol-Induced gastric lesion rats (1mL-1 rat)

Group III- Ethanol-Induced gastric lesion rats orally treated with Avocado fruit extract at a dose of 300mg/kg b.w., for a period of 15days.

Group- IV Ethanol induced gastric lesion rats orally treated with Ranitidine (100mg/kg b.w.,) for a period of 15days.

 

Indomethacin-Induced Gastric lesion Model

The experimental set up adopted for indomethacin–induced gastric lesion model was as follows:

Group I -Control rats.

Group II- Indomethacin-Induced gastric lesion rats (100mg/kg. p.o).

Group III- Indomethacin- Induced gastric lesion rats orally treated with Avocado fruit extract at a dose of 300mg/kg b.w., for a period of 15days

Group IV Indomethacin-Induced Gastric lesion rats orally treated with Ranitidine (100mg/kg b.w.) for a period of 15 days.

The treatment schedule was once a day and the rats were weighed periodically. At the end of the experimental period, all the groups of rats were subjected to pylorus ligation according to the procedure of12 as modified by13. Feed was withheld 12h prior to the operative procedure. The rats were anaesthetized with ether and the stomach was open through a mid-line incision. The pylorus was secured and lighted with silk sutures; proper care was taken not to ligate the blood vessel. The gastric walls were closed and the animals were allowed to recover from anesthesia. After pyloric ligation, drinking water was withheld and the gastric juice was allowed to collect for a period of 4h. The rats were then killed by an overdose of ether and the abdomen was removed after clamping the esophagus.

 

The gastric mucosa was washed with 3ml of lukewarm distilled water and collected in graduated centrifuge tubes. The gastric juice and washing were homogenized and centrifuged at 500rpm for 5min. The biochemical parameters assayed in gastric juice include gastric volume, total acidity, pH and glycoproteins. Dissolved mucosa substances were estimated in 90% alcoholic precipitate of gastric juice14. The precipitate thus obtained was either dissolved in 1ml of 0.1N sodium hydroxide or 1ml of 0.1N sulphuric acid. The former was used for the estimation of protein, total hexose, hexosamine and fucose, while the latter was used for the estimation of sialic acid. Hexose was estimated by the method of15. Hexosamine was estimated by its color reaction with Ehrlich’s reagent16. Sialic acid was estimated by the method of17. Fucose   was estimated by the method of18. Total protein was estimated by the method of19. Ratio of total carbohydrate (TC= sum of total hexose, hexosamine, fucose and sialic acid) to protein (P) was used as the index of mucin activity.

 

Determination of Degree of Gastric lesions

The surface area (A) mm2 covered by each lesion was measured20 and the sum of erosion areas per rat abdomen was calculated. Percentage Gastric lesion surface was calculated through Ulcer Index (US).

 

%US =

 

Ulcer index was calculated from percentage gastric lesion surface as described by21.The following scores, was used in order to calculate ulcer index; 0. No gastric lesion; 1.US<0.5; 2. 0.5=2.5; 3.2.5=5; 4.5=10; 5.11=15; 6.15=20; 7.20=25; 8.25=30; 9.30=35; 10.US>35.

 

Statistical Analysis

The values are expressed as mean+ SD for six rats in each group. All the data were analyzed with SPSS/7.5 student software. Hypotheses testing method included one way analysis of variance (ANOVA) followed by post hoc performed with Least Significant Difference (LSD) test. The p value of less than 0.05 was considered to indicate statistical significance.   

 

RESULTS:

Pretreatment studies

 Table 1 indicates the ulcer index and gastric lesion surface in control and experimental groups of both gastric lesion models.  A marked increase was observed in gastric lesion surface and ulcer index of both the gastric lesion-induced groups of rats. In pretreated groups of rats, a significant decrease in gastric lesion severity was evident by decreased ulcer index.

 

Table 1: Effect of pretreatment with Avocado fruit extract on indomethacin-induced and ethanol induced gastric lesion rats

Groups

Gastric Lesion surface (%)

Ulcer index

Control

0.0

0

Indomethacin-induced gastric lesion

41.3+ 3.1a*

9

Avocado + Indomethacin

2.4 +0.15b*

2

Ethanol induced gastric lesion

20. 5+ 0.12b*

6

Avocado + Ethanol

23+ 0.14b*

1

Values are expressed as Mean + SEM of six animals in each group. One way ANOVA followed by post hoc test (LSD). * P<0.05. Comparisons are made between a control, b indomethacin, Ulcer index: No gastric lesion; 1. US<0.5; 2. 05< 2.5; 3. 2.5< 5; 4.5< 10; 5.11< 15; 6.15< 20; 7.20< 25; 8.25< 30; 9. 30< 35; 10.US>35

 

 

Post Treatment Studies

Table 2 and 3 show the percentage-gastric lesion surface, ulcer index, total gastric volume, gastric acidity and pH of control and experimental groups of rats in both gastric lesion models. A high degree of ulcer index and gastric lesion surface were obtained in both the gastric lesion -induced groups of rats when compared to control animals. Ulcer index and gastric lesion severity were found to be comparably higher in indomethacin-induced gastric lesion rats. Treatment with Avocado fruit extract exhibited decrease in both ulcer index and severity of gastric lesion.

 

A significant increase was observed in the volume, acidity and a concomitant decrease in pH of gastric juice in both indomethacin and ethanol induced groups of rats. Administration of Avocado fruit extract was observed to significantly decrease the acidity, volume and increase the pH in the gastric juice of both the gastric lesion -induced rats.  The beneficial effect of ranitidine was more pronounced in indomethacin-induced gastric lesion when compared ethanol-induced gastric lesion group.

 

Levels of Glycoprotein     

The levels of glycoprotein contents and TC: P ratio in the gastric juice of control and experimental groups of rats on indomethacin induced and ethanol induced are presented in table 4 and 5, respectively. From this result it is evident that the level of hexose, hexosamine, sialic acid, fucose and TC: P ratios in both the gastric lesion model were


Table 2: Effect of Avocado fruit extract on the extent of gastric lesion in control and indomethacin induced gastric lesion groups of rats

Parameters

Control

Indomethacin induced gastric lesion

Indomethacin+ Avocado

Indomethacin+ Ranitidine

Gastric lesion surface (%)

0.0

80.2+ 6.4a*

1.3+ 0.8b*

1.3+ 0.20b*

Ulcer index

0

11

3

2

Total gastric Volume (ml)

2.23+0.15

4.54 +0.23a*

2.89+ 0.24b*

3.11+ 0.34b*

Gastric acidity (mEq/L)

3.87+0.43

6.29+ 0.65a*

3.79 +0.22b*

4.12+ 0.45b*

 pH

4.56+0.23

2.4+ 0.32a*

4.11+ 0.45b*

3.45+ 0.46b*

Values are expressed as Mean + SEM of six animals in each group, One way ANOVA followed by post hoc test (LSD). * P<0.05. Comparisons are made between a control, b indomethacin, Ulcer index: No gastric lesion; 1. US<0.5; 2. 05< 2.5; 3. 2.5< 5; 4.5< 10; 5.11< 15; 6.15< 20; 7.20< 25; 8.25< 30; 9. 30< 35; 10.US>35

 

 

Table 3: Effect of Avocado fruit extract on the extent of gastric lesion in control and ethanol-induced gastric lesion groups of rat

Parameters

Control

Ethanol-induced gastric lesion

Ethanol + Avocado

Ethanol+ Ranitidine

Gastric lesion surface (%)

0.0

60.2+ 5.4a*

1.2+ 0.09b*

1.5 +0.10b*

Ulcer index

0

12

2

3

Total gastric Volume ml)

2.63+0.25

4.74+ 0.63a*

2.69+ 0.34b*

3.08+ 0.24b*

Gastric acidity (mEq/L)

3.67+ 0.45

6.79+ 0.55a*

3.89 +0.42b*

4.92+ 0.95b*

 pH

4.7+0.43

2.6+ 0.31a*

4.09+ 0.25b*

3.49+ 0.76b*

Values are expressed as Mean + SEM of six animals in each group, One way ANOVA followed by post hoc test (LSD). * P<0.05. Comparisons are made between a control, b ethanol, Ulcer index: No gastric lesion; 1. US<0.5; 2. 05< 2.5; 3. 2.5< 5; 4.5< 10; 5.11< 15; 6.15< 20; 7.20< 25; 8.25< 30; 9. 30< 35; 10.US>35

 

 

 

Table 4: Levels of glycoprotein contents and TC: P ratio in the gastric juice of control and experimental groups on indomethacin –induced gastric lesion rats

Parameters

Control

Indomethacin Induced gastric lesion

Indomethacin+ Avocado

Indomethacin+ Ranitidine

Hexose (µmg/L)

405.6+ 27.4

310.2+ 22.3a*

398. +5 28.5b*

412.5+ 24.4b*

Hexosamine(µmg/L)

178.3+ 12.9

115.4+  9.2a*

169.2 +12.6b*

156.8+ 10.9b*

Sialic acid (µmg/L)

34.4 +2.5

25.9+ 3.0a*

37.8+ 2.5b*

37.9+ 3.9b*

Fucose (µmg/L)

37.2+ 4.2

28.3 +2.6a*

34.7+ 2.8b*

35.6 +3.9b*

Protein (µmg/L)

267.4+ 12.9

334.1+ 34.0a*

256.1+ 19.78b*

257.1+ 18.9b*

TC: P ratio

3.90+ 0.16

2.60+  0.19a*

4.09+  0.32b*

3.78+  0.37b*

Values are expressed as Mean + SD of six animals in each group. One way ANOVA followed by post hoc test (LSD). * P<0.05. Comparisons are made between a control, bindomethacin.

 


 

considerably lowered when compared to control groups of rats.  Oral administration of Avocado fruit extract significantly elevated (p<0.05) the levels of glycoprotein contents after 15 days of treatment in both the gastric lesion-induced groups.

 

DISCUSSION:

 In most cases, the stable incident of gastric lesion in rat models provides a powerful and convenient tool for the investigation of therapeutic modalities for the disease and for its complications. Non-Steroidal Anti-inflammatory Drugs (NSDAIDs) like indomethacin and aspirin are known to induce numerous punctiform and filiform gastric lesions during the course of anti-inflammatory therapy and hence indomethacin induced gastric lesion model was used in the present study. Although the Mechanisms underlying the ulcerogenicity of indomethacin are not completely understood, inhibition of prostaglandin synthesis may be an important22. This view is supported by the fact that prostaglandins normally have a protective function in the stomach by maintaining gastric microcirculation23 and caused gastric secretion of bicarbonate and mucus24. Consumption of alcohol produce sever hemorrhagic lesions in the gastric mucosa and hence ethanol induced gastric lesion model was included in the present study. Ethanol-induced gastric lesion formation may be multifactor. The factors involved in the formation of gastric lesion using ethanol have been described25. Further26, has suggested that the gastric wall mucus depletion induced by ethanol is one of the pathogenic mechanisms responsible for gastric lesion. The numbers of lesion present on the gastric mucosa are indicative of the severity of gastric lesion disease27. The diameters of the lesion are used for the determination of ulcer index, a measure of gastric lesion in the gastric mucosa.

 

The observed decrease in the ulcer index in P. Avocado fruit extract pretreated groups of rats may be due to its anti-secretory or cytoprotective proteins or both. Through, the mechanism of gastric lesion formation by indomethacin as well as ethanol is quite different, the efficacy of the drug was found to be the same in controlling the gastric lesion.

 

Although there is considerably controversy about the role of mucus in the prevention of gastric mucosal injury28, the gastric mucus coat is considered to be important both in preventing damage to the gastric epithelium as well as in facilitating its repair. The incidence of ethanol-induced gastric lesions, which is predominant in the glandular part of the stomach, has been reported to stimulate the formation of leukotriene C4 (LT4C4)   resulting in the damage of rat gastric mucosa 29.

 

Administration of Avocado fruit extract enhanced the mucosal resistance and thus resulted in decrease in ulcer index and gastric lesion surface. The antisecretory drug ranitidine, also markedly inhibited the indomethacin-induced gastric lesions. These results suggest that the anti-gastric lesion activity of the Avocado fruit extract against indomethacin-induced gastric lesion might also be related its antisecretory effect.

 

Ranitidine did not overcome the mucus depletion induced by ethanol, since it acts via blocking of H2-receptors. This is in accordance with the previous reports30. On contrary, Avocado fruit extract administration resulted in decreased ulcer index. The mucus depletion by the ethanol was overcome by Avocado fruit extract which underline its cytoprotective nature.

 

It may also be proposed that the decrease in gastric lesion severity by Avocado fruit may be attributed to its active ingredients with gastric-protective nature. The phytochemical analysis revealed the presence of tannins, saponins and flavanoids.These substances known to affect the integrity of mucous membranes31. Tannins are known to protect the outermost layer of mucosa and to render it less permeable and more resistant to chemicals and mechanical injury or irritation and thus prevent gastric lesion development32. Flavanoids have also been reported to offer some protection in gastric lesion development by increasing capillary resistance and improving microcirculation33.

 

Acidity plays an important role in the pathogenesis of indomethacin induced gastropathy. Gastric mucosal damage induced by indomethacin is amplified by the presence of high concentration of acid into the gastric lumen34. Indomethacin induced damage to rat gastric mucosa is markedly dependent on luminal pH35. Gastric acidity may potentially facilitate indomethacin induced mucosal damage by two mechanisms:(i) by enhancing gastric absorption of these drug or (ii) by amplifying mucosal injury once mucosal defense have been impaired by the decrease in prostaglandin synthesis34. Stimulation of mucus secretions such as glycoprotein and mucin by Avocado fruit extract helps in decreasing the volume and acidity of gastric juice. Further, hyposecretory nature of Avocado fruit extract gastric lesion-induced rats may further help in decreasing the volume, pH, and acidity of gastric juice towards near normal levels. Thus, normalization of gastric juice acidity may indirectly help in healing of gastric lesion Avocado treated gastric lesion rats.

 

Glycoproteins are the important constituents of plasma membrane and specific intercellular organelles such as Golgi complexes, lysosomes and secretory granules. Surface mucus cells and mucus neck cells of gastric mucosa secrete mucus by exocytosis36. The main components of gastric mucus are the acidity glycoprotein, sialic acid and neutral mucopolysaccharides like total hexoses, hexosamine and fucose. These glycoproteins are of importance for their specific properties such as gel formation and viscosity. Glycoproteins are obligatory components of mucus and their quantitative determination has been as a measure of mucus formation37. A decrease in the synthesis of sulphated mucus glycoprotein has been implicated in the etiology of peptic gastric lesion38.

 

The observed decease in the level of glycoprotein moieties both in gastric juice of gastric lesion groups of rats may be attributed to two factors namely (a) decreased activity of defense mechanisms as s result of damage to the gastric mucosa and (b) disintegration and degradation of glycoprotein moieties into their simpler components in the process of gastric lesion induced by ulcerogens.

 

Two main features of the mucous layer are its thickness and turnover rate. These two processes are great value in protecting the mucosal layers from the offensive factors39. The mucosal layer is a dynamic entity in which the surface cells are continuously renewed40. The observed decease in the levels of sialic acid and hexosamine levels may be attributed to the decreased production or turnover of mucus. The mucus possessing fewer amounts of sialic acid and hexosamine is prone for easy degradation41. Treatment with Avocado fruit extract antagonizes the aggressive factors, which play a crucial role in the pathogenesis of gastric lesions and augment defensive factors to protect the gastric mucosa from gastric lesion. The increase in the levels of glycoproteins, particularly sialic acid and hexosamine in the extract treated groups indicate the increase in the production of mucus, thereby possibly protecting the gastric mucosa in both gastric lesion models. The efficacy of the extract was more or less same in both the models and showed promising anti-gastric lesion activity more than that of ranitidine.

 

Tannins, one of the constituents of Avocado extract, form a pellicle over the lining of gastric mucosa to resist the attack of proteolytic enzymes42. Thus resistance to proteolysis may help in the restoration of glycoprotein moiety of gastric mucosa in Avocado treated gastric lesion rats. Further, flavanoids have been reported to be present in Avocado fruit extract, flavanoids might play a role in stabilizing the antioxidant status of the gastric mucosa, which may have maintained its glycoprotein moiety. Thus, Avocado fruit extract may have ameliorated glycoprotein abnormalities through its action on pepsin-mediated proteolysis.

 

Thus, the present investigation establishes the gastro-protective nature of Avocado fruit extract and the protective effect may be mediated by defensive mucosal factors.

  

ACKNOWLEDGMENT:

The authors would like to thank Mr.G.Manoharan and P. Selvarama Lakshmi, Lecturers in Mizan-Tepi University who made this research work possible by assisting in calculating statistical data and computational work.

 

REFERENCES:

1.       Clinch, J., 1989. Perinatal mortality 1968 and 1987. Iraq. J. Med. Sci., 158: 148-149.

2.       Allen, A., G. Flemstrom, A. Garner and E. Kivilaakso, 1993. Gastroduodenal mucosal protection. Physiol. Rev., 73: 823-857.

3.       Nordman, H., J.R. Davies, A. Hermann, N.G. Karlsson, G.C. Hansson and I. Carlstedt, 1997.      Mucus glycoproteins from pig gastric mucosa: Identification if different mucin populations from the surface epithelium, Biochem. J., 326: 903-910.

4.       Alarcon, de. L.A., C. Lastra, M.J. Martin and V. Motilva, 1994. Antiulcer and gastroprotective effect of quercetin, a gross and histologic study. Pharmacology, 48:56-63.

5.       McGuigan, J.E., 1991. Peptic ulcer  and Gastritis, in Harrisons Principles of Internal Medicine, 12Edn., Wilson, J.D., E. Braunwald, K.J. Isselbacher, R.G. Peterdorf, J.B. Martin,A.S. Fauchi and R.K. Root (Eds.). McGraw-Hill, New York, pp: 1229.

6.           Martelli, A., F. Mattioli, E. Mereto, G. Brambilla Campart, D. Sini, G. Bergamaschi and G. Brambilla, 1998. Evaluation of omeprazole genotoxicity in a batter in vitro and in vivo- assays. Toxicology, 30: 29-41.

7.       Shimokawa, M., K. Yamamoto, J. Kawakami, Y.Sawadu and T. Iga, 1996. Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice. Toxicol. Applied Pharmacol., 136: 317-323.

8.       Goel, R.K., Gupta, R. Shankar and A.K. Sanyal, 1986.anti-ulcerogenic effect of banana powder (Musa, sapientum  Var. paradisiaca) and its effects on mucosal resistance. J. Ethanopharmacol., 18: 33-44.

9.       Sairam, K., C.V. Rao and R.K. Goel, 2001. Effect of Centella asiatica Linn. on physical and chemical factors induced gastric ulceration and secretion in rats: Ind. J. Exp. Biol., 39: 137-142.

10.     Morise, Z., S. Komatsu, J.W. Fuseler, D.N. Granger, M. Perry, A.C. Issekutz and M.B. Grisham, 1998. ICAM-I and P-selection expression in a model of NASID-induced gastropathy. Am. J. Physiol., 274: G246-252.

11.     Robert, A, J.E. Nezamis, C. Lancaster and A.J. Hauchar, 1979. Cytoprotection by prostaglandin in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology, 77: 433-443.

12.     Shay, H., S.A. Komarow, S.S. Fels, D. Mereanze, M. Gruentein and H. Siplet, 1945. A simple method for the uniform production of gastric ulceration. Gastroenterology. 5: 43-61.

13.     Tan, P.V., N.G. Nditafon, M.P. Yewah, T. Dimo and F.J. Ayafor, 1996. Eremomastex speciosa: Effects of leaf aqueous extract on ulcer formation and gastric secretion in rats. J. Ethanopharmacol., 54: 139-142.

14.     Shah, P.J., M.S. Gandhi, M.B. Shah, S.S. Goswami and D. Santami, 2003. Study of Mimusops elengi bark in experimental gastric ulcer. J. Ethanopharmacol., 89: 305-311.

15.     Niebes, P., 1972. Determination of enzyme and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin. Chim. Ac., 42: 399-408.

16.        Wagner, W.D., 1979. A more sensitive assay discriminating galactosamine and glycosamine in mixtures. Ana. Biochem., 94: 394-396.

17.     Warren, L., 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem., 234:1971-1975.

18.     Dische, Z. and L.B. Shettles, 1948. A specific colour reaction for methyl pentose and spectrophotometric micro method for determination. J. Biol. Chem., 175: 595-603.

19.     Lowry, O.H., N.J. Rosenborough, A.L. Farr and R.J. Randall, 1951. Protein measurement with folin phenol reagent. J. Bio. Chem., 193: 265-275.

20.     Murakami, S., I. Arai, M. Muramatsu, S. Otomo, K. Baba, T.Kido and M. Kozawa, 1992. Inhibition of gastric H+, K+, ATPase and acid secretion  by  cassigarol A, a polyphenol from cassia garrettiana Craib, Biochem. Pharmacol., 44: 33-37.

21.     Takeuchi, K., S. Okabe and K. Takagi, 1976. A new model of stress ulcer in the rat with pylorus ligation and its pathogenesis. Am. J. Dig. Dis., 21: 782-788.

22.     Vane, J.R., 1971. Inhibit of prostaglandin synthesis as a mechanism of action for aspirin like drugs. Natl. New Biol., 231: 232-235.

23.     Ferrerira,S.H., S. Moncada and J.R. Vane, 1974. Proceedings: Potenitation by prostaglandins of the nociceptive activity of bradykinin in the dog knee joint. Brazilian J. Pharmacol., 50: 461.

24.     Garner, A., G. Flemstrom and J.R. Heylings, 1979. Effects of anti-inflammatory agents and prostaglandins on acid and bicarbonate secretions in the amphibians isolated gastric mucosa. Gastroenterology., 77: 451-457.

25.     Lange, K., B.A. Peskar and B.M. Peskar, 1985. Stimulation of rat mucosal leukotriene formation by ethanol. Naunyn Schmiedebeg’s. Archives fur Parmakologies, 3305: R-27.

26.     Koo, M.W., C. W. Ogle and C.H. Cho, 1986. Effects of Verapamil, carbenoxolone and Nacetylcysteine on gastric wall mucus and gastric ulceration in stressed rats. Pharmacology, 32: 326-344.

27.     West, G.B., 1982. Testing for drugs inhibiting the formation of gastric ulcer. J. Pharmacol. Meth., 8: 33-37.

28.     Henagan, J.M., G.S. Smith, K.L. Schmidt and T.A. Miller, 1986. N-acetyl-cystein and prostaglangin: Comparable protection agnist experimental ethanol injury in the stomach independent of mucus thickness. Ann. Sugery, 204:689-704.

29.     Cho, C.H., C.W. Ogel and S. Dai, 1985. A study on the etiology of reserpin gastric ulceration and the antiulcer action of solcoseryl in rat stomach. J.Pharm. Pharmacol., 37 158-149.

30.     Zauberman, G., M.J. Montero, M.A. Sevilla and L. San Roman, 1998. Pharmacology of JB-9315. A new selective histamine H2-recetpro antagonist. General Pharmacol., 30: 181-189.

31.     Oliver, B., 1960. Medicinal plants in Nigeria. Ibadan: Nigerian College of Arts and Science and Technology.

32.     Asuzu, IU. and O.U Onu, 1990. Antigastric lesion  activity of ethanolic extract of combretum dolichopetalum root. Intl. J. Crude. Dru. Res., 28: 27-32.

33.     Hashizume, T., K. Hirokawa, S.  Aibara, H. Ogawa ansd A. Kasahara, 1978. Pharamacolgical and histological studies of gastric mucosal lesion induced by serotonin in rats. Archiv. Inttl. Pharmacodynamic. Therapeutics, 236:96-108.

34.     Yeomans, N.D., M.V. Skeljo and A.S. Giraud, 1992. The role of acid regulation in the treatment of NSAID-induced mucosal damage. Digestion, 51: 3-10.

35.     Elliott, S.L., Ferris, A.S. G.A. Cook, M.V. Skeljo and N.D. Yeomans, 1996. Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH. Clin. Exp. Pharmacol. Physiol., 23: 432-434.

36.     Zalewsky, C.A. and F.G. Moody, 1979.  Mechanisms of mucus related in exposed canine gastric mucosal. Gastroenterology, 77: 719-729.

37.     Lukie, B.E. and G.G. Froster, 1972. Synthesis of intestinal cycoproteins.  Inhibition of (I-14C) glucosamine incorporation by sodium salicylate in vitro. Biochem. Biophys. Acta, 273: 380-388.

38.     Younan, F., J. Pearson, A. Allen and C. Venables, 1982. Changes in the structure of the mucus gel on the mucosal surface of the stomach in association with peptic ulcer disease. Gastrocenterol, 82: 827-831.

39.     Allen, A., 1978. Structure of gastrointestinal mucus glycoproteins and the viscous gel forming properties of mucus. Br. Med. Bul., 134: 28-33.

40.     Bickel, M. and G.L. Jr. Kauffman, 1981. Gastric gel mucus thickness: Effect of distention 16, 6- dimethyl prostaglandin E2 and carbenoxolone. Gastroenterology, 80: 770-775.

41.     Kerss, S., A. Allen and A. Garner, 1982. A simple method for measuring thickness of mucus gel layer adherent to rat, frog and human gastric mucosa: Influence of feeding prostaglandin N-acetylcystein and other agent. Clin. Sci., (Lond) 63:187-195.

42.     John, T.A. and A.O. Onabanjo, 1990. Gastroprotective effects of an aqueous extract of Entandrophragma utile bark in experimental ethanol-induced peptic gastric ulceration in mice and rats. Ethnopharmacol., 29: 87-93.

 

 

Received on 10.04.2010

Accepted on 10.07.2010     

© A&V Publication all right reserved

Research J. Pharmacology and Pharmacodynamics. 2(4): July-August 2010, 303-308